SUNNYVALE, Calif., — Arrayit Corporation (OTCQB: ARYC) is pleased to announce that Arrayit Diagnostics, Inc. (“”AD””) has secured a financing commitment from American Equity Fund, LLC to purchase up to $8 million of the common stock of AD. This financing will commence upon the completion, filing, and approval by the SEC of the S-1 Registration […]

Redwood City, CA – – Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, today announced a partnership with Life Technologies Corporation to develop and deliver a joint solution for rapid, high-confidence interpretation of molecular profiling information from Life Technologies’ diagnostic tests. Ingenuity Systems’ unique software and content will be provided to interpreting […]

SEATTLE, Wash. – NanoString Technologies, Inc., a privately-held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of James A. Johnson as the company’s new Chief Financial Officer (CFO). Mr. Johnson assumes this role from Wayne Burns who will remain with the company in his new position […]

KANSAS CITY, Mo. – Today investigators at Children’s Mercy Hospitals and Clinics in Kansas City reported the first use of whole genome information for diagnosing critically ill infants. As reported in Science Translational Medicine, the team describes STAT-Seq® , a whole genome sequencing approach – from blood sample to returning results to a physician – […]

INDIANAPOLIS, — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. availability of a new HIV-1 viral load test based on the company’s proprietary dual-target approach. The COBAS TaqMan HIV-1 Test v2.0 for use with the High Pure System enables labs to combine an FDA-approved process for manual specimen preparation with an automated real-time […]

Mountain View, CA — Genia Technologies, Inc. today announced a collaboration with investigators at Columbia University and Harvard University to develop a nanopore-based sequencing system that will accelerate the use of DNA sequencing in the clinic. The three-way collaboration focuses on the development of a single molecule sequencing system combining Genia’s standard complementary metal-oxide semiconductor […]

San Francisco, Calif., – CollabRx, Inc. (NASDAQ: CLRX) today announced a multi-year partnership agreement with Life Technologies Corporation for development and commercialization of CollabRx technology and content resources to be used in conjunction with Life Technologies’ global cancer diagnostics development and its laboratory developed test services business. The agreement represents a major step forward by […]

Frederick, MD —— Akonni Biosystems, a life science tools/molecular diagnostics company, has been awarded a $280,784 grant by NIH to develop a fully automated sample preparation workstation for isolating nucleic acids from lysis-resistant targets. The system will initially be used for general research, and eventually in clinical settings. This award enables Akonni to develop a […]

Milford, Mass.,– SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics, has received a $299,771 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases, an agency of the National Institutes of Health (NIH). The […]

Paris, France,- Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces in the Journal of Biological Chemistry, one of the most respected scientific journals in the world, the publication of a new approach regarding the targeted modification of DNA. The manuscript unmasks novel perspectives and broadens the scope of TALENs TM technology to new therapeutic […]